Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2003
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1444496A New use of lipase inhibitors
09/24/2003CN1444495A New pharmaceutical composition
09/24/2003CN1444475A Preparation with vascular protective and anti-oxidative effect and use thereof
09/24/2003CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1443575A Medicine for curing metabolic syndrome
09/24/2003CN1443574A Ranzhi Jianfei oral preparation for reducing weight
09/24/2003CN1443569A Preparation method of cordyceps biological activity multivitamin intensifying agent
09/24/2003CN1443568A Preparation method of ganoderma biological activity multivitamin intesifying agent
09/24/2003CN1443562A Medicinal and edible product for supportive prevention and therapy of atypical pneumonia and safely reducing weight and its preparation method
09/24/2003CN1443552A Gefen Yuyan soluble granules
09/24/2003CN1443544A Chinese medicine Jiangtang Tongmailing for curing diabetes and preventing and curing complicating diseases and its preparation method
09/24/2003CN1443540A Chitosan derivative
09/24/2003CN1121869C Zhengtang capsule
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624202 Inhibitors of copper-containing amine oxidases
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624185 Drugs at least one lipid- or triglyceride-lowering active compound; and carriers for lipid metabolism
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624161 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624146 MTS represents a membrane-transfer amino acid sequence; X represents a direct bond or a linker sequence; and NLS represents a nuclear localization amino acid sequence, or a pharmaceutically acceptable salt thereof for weight reduction
09/23/2003US6624141 Protamine fragment compositions and methods of use
09/23/2003CA2295992C Method for preparing a substituted perhydroisoindole
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2091651C Agent for suppresion and interception of mailard reaction
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076442A1 Purine derivatives as kinase inhibitors
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076414A2 Aryl substituted pyrimidines and the use thereof
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076404A1 Chain oligolactic acid thioester
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076393A1 Salts of nateglinide
09/18/2003WO2003075977A2 Agglomerated particles for aerosol drug delivery
09/18/2003WO2003075950A1 Minimising body weight gain in insulin treatment
09/18/2003WO2003075948A1 NOVEL FUNCTION OF Wnt AND APPLICATION THEREOF TO TREATMENT OF DISEASES
09/18/2003WO2003075946A2 Treatment of type i diabetes mellitus using growth hormone antagonist
09/18/2003WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
09/18/2003WO2003075939A1 Soybean saponin-containing material and process for producing the same
09/18/2003WO2003075933A1 Composition for reducing blood glucose and cholesterol
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003WO2003075931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity
09/18/2003WO2003075924A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/18/2003WO2003075923A1 Vdac regulator
09/18/2003WO2003075922A1 Nitrogen monoxide synthase inhibitors
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075910A1 Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure
09/18/2003WO2003075906A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
09/18/2003WO2003075858A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075850A2 Methods for alzheimer's disease treatment and cognitive enhancement
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003075676A1 Probiotic delivery system
09/18/2003WO2003054159A3 Modulating insulin receptor signaling through targeting facl
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003051893A3 Improvements in pharmaceutical compositions
09/18/2003WO2003051807A3 Improvements in pharmaceutical compositions
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003045392A3 Use of n-(indolcarbonyl-)piperazine derivatives
09/18/2003WO2003033808A3 Composition and method for treating diabetes
09/18/2003WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003WO2003012139A3 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene
09/18/2003WO2002100323A3 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002064793A3 G protein-coupled receptor-like proteins and nucleics acids encoding same
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176698 Such as (R)-2-cyclopentyl-7,8-dihydro-8-(4-picolyl)-4-(n-propyl)-1H-imidazo(2,1 -i)purin-5(4H)-one d-tartaric acid, which has glucose concentration-dependent insulin secretion promoting action/hypoglycemic activity; antidiabetic agents
09/18/2003US20030176694 Fused heterocyclic compounds
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176514 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
09/18/2003US20030176502 Pravastatin pharmaceutical formulations and methods of their use
09/18/2003US20030176501 For use in inhibiting HMG-CoA reductase; therapy and prophylaxis of hypercholesterolemia, atherosclerotic disease
09/18/2003US20030176498 Inhibitors of alpha4mediated cell adhesion
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
1 ... 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 ... 1298